Novel 1-[5-(4-bromophenoxy)pentyl]-3-(2-arylamino- 2-oxoethyl)uracils and their antiviral properties

The title compounds were prepared from 1-[5-(4-bromophenoxy) pentyl]uracil by the introduction of N -arylacetamide moiety at the 3-position, the better approach involving the use of N -aryl-2-chloroacetamides as the reactants. Antiviral activity of the obtained compounds was estimated.